RESUMO
BACKGROUND: Non-AIDS defining cancers (NADCs) have been an increasing cause of morbidity and mortality in patients with HIV. There is no data on the spectrum of NADCs in Mexico. We describe the type of neoplasms, clinical characteristics, and outcomes of HIV-infected patients with NADCs. METHODS: We conducted a retrospective study of all patients with confirmed diagnosis of NADC attending the HIV/AIDS clinic at the National Cancer Institute in Mexico City (a tertiary-care center for adult patients with cancer) from January 1990 to December 2016. RESULTS: From 1126 HIV-positive individuals seen at the institute since 1990, 127 (11.3%) were diagnosed with NADCs; seven patients developed two NADCs during their follow-up. At diagnosis of NADC median age was 43.7 ± 10.9 years; 101 (79.5%) were male; median CD4 was 273 cells/mm3, 70 patients had a CD4 count of > 200 cells/mm3, 73 had undetectable HIV viral load and 82 had taken combined antiretroviral therapy (cART) for more than 1 year. The most frequent NADCs were in men, Hodgkin lymphoma (34.3%) followed by anal cancer (15.7%), whereas in women, were vulvo-vaginal cancers associated to human papilloma virus (HPV) (51.8%), followed by breast cancer (25.9%). The main risk factor associated with death was cancer progression or relapse (OR, 28.2, 2.5-317.1; p = 0.007). CONCLUSIONS: HL- and HPV-related neoplasms are the commonest NADC in a cancer referral hospital from a middle-income country with universal access to cART since year 2005. Screening for early anogenital lesions should be emphasized in patients with HIV. It is essential to establish multidisciplinary groups involving Hemato-oncologists, Oncologists, Gynecologists, and HIV Specialists in the treatment of these patients.
Assuntos
Infecções por HIV/complicações , Infecções por HIV/epidemiologia , Neoplasias/complicações , Neoplasias/epidemiologia , Centros de Atenção Terciária , Síndrome da Imunodeficiência Adquirida/complicações , Síndrome da Imunodeficiência Adquirida/epidemiologia , Síndrome da Imunodeficiência Adquirida/imunologia , Síndrome da Imunodeficiência Adquirida/virologia , Adulto , Contagem de Linfócito CD4 , Coinfecção , Feminino , Infecções por HIV/imunologia , Infecções por HIV/virologia , Humanos , Masculino , México/epidemiologia , Pessoa de Meia-Idade , Neoplasias/imunologia , Medição de Risco , Fatores de Risco , Carga ViralRESUMO
The worldwide spread of carbapenem- and polymyxin-resistant Enterobacterales represents an urgent public-health threat. However, for most countries in the Americas, the available data are limited, although Latin America has been suggested as a silent spreading reservoir for isolates carrying plasmid-mediated polymyxin resistance mechanisms. This work provides an overall update on polymyxin and polymyxin resistance and focuses on uses, availability and susceptibility testing. Moreover, a comprehensive review of the current polymyxin resistance epidemiology in the Americas is provided. We found that reports in the English and Spanish literature show widespread carbapenemase-producing and colistin-resistant Klebsiella pneumoniae in the Americas determined by the clonal expansion of the pandemic clone ST258 and mgrB-mediated colistin resistance. In addition, widespread IncI2 and IncX4 plasmids carrying mcr-1 in Escherichia coli come mainly from human sources; however, plasmid-mediated colistin resistance in the Americas is underreported in the veterinary sector. These findings demonstrate the urgent need for the implementation of polymyxin resistance surveillance in Enterobacterales as well as appropriate regulatory measures for antimicrobial use in veterinary medicine.
Assuntos
Farmacorresistência Bacteriana/genética , Escherichia coli/efeitos dos fármacos , Escherichia coli/genética , Klebsiella pneumoniae/efeitos dos fármacos , Klebsiella pneumoniae/genética , Polimixinas/farmacologia , Animais , Antibacterianos/farmacologia , Proteínas de Bactérias/genética , Escherichia coli/metabolismo , Proteínas de Escherichia coli/genética , Humanos , Klebsiella pneumoniae/metabolismo , Proteínas de Membrana/genética , Testes de Sensibilidade Microbiana , América do Norte , Plasmídeos/genética , América do Sul , beta-Lactamases/genéticaRESUMO
INTRODUCTION: Higher prevalence of osteopenia and osteoporosis in HIV positive patients compared to non-infected population has been recognized. However, cancer patients have a higher risk of bone loss and fractures that is multifactorial. The aim of the study was to describe the prevalence of osteopenia and osteoporosis in HIV positive women with history of treated cancer. METHODS: Between January 2018 and December 2019, women aged >40 years, HIV+ with a history of cancer diagnosis, who attended the AIDS Cancer Clinic at Instituto Nacional de Cancerología, Mexico City, and who had a dual X-ray absorptiometry performed during the study period were included. Two control groups (CG)-HIV negative women with history of cancer (CG1) and non-HIV, non-cancer women (CG2)-were matched by age 1:1. RESULTS: Forty-eight patients in each group were included; the mean age was 51.1 ± 8.1 years. Osteopenia was found in femoral neck in 54.2% (HIV+), 37.5% (CG1), and 27.1% (CG2), p = 0.02; in spine was 35.7%, 47.9%, and 31.2%, respectively, p = 0.442. Osteoporosis in femoral neck was documented in 12.5%, 2.1%, and 0% in HIV+, CG1, and CG2 (p = 0.03), and in the spine was 47.9%, 16.7%, and 14.6%, respectively (p = 0.002). CONCLUSION: HIV patients with a history of treated cancer have a much higher prevalence of osteoporosis when compared with same-aged HIV-uninfected women with and without cancer. It is necessary to monitor Bone Mineral Density periodically, and all patients should be encouraged to make lifestyle changes, such as avoid tobacco and alcohol, and to increase exercising.
RESUMO
BACKGROUND: Disseminated Kaposi sarcoma (DKS) is present in patients with advanced HIV infection in whom co-infection with other opportunistic pathogens can occur. Bone marrow (BM) aspirate and biopsy comprise a robust diagnostic tool in patients with fever, cytopenias, and abnormal liver tests. However, the yield in patients with DKS has not been determined. OBJECTIVE: The aim of this study was to evaluate the utility of BM aspirate and biopsy in patients with DKS. METHODS: We included 40 male patients with a recent diagnosis of DKS. BM aspirate and biopsy was performed as part of the workup to rule out co-infections. RESULTS: In four patients, Mycobacterium avium complex (MAC) was recovered from culture. In other four patients, intracellular yeasts were observed in the Grocott stain, diagnosed as Histoplasma. The yield of BM was calculated in 20%. Only 12 patients (30%) had fever and 11 (27.5%) had pancytopenia. Alkaline phosphatase (ALP) above normal values and C-reactive protein (CRP) were higher in patients with positive results for BM than in those with negative results (63% vs. 21.9%, and 3.0 vs. 1.2 mg/L; p = 0.03 in both comparisons). No differences were found when complete blood-count abnormalities were compared. CONCLUSION: We recommend performing a BM aspirate for stains, culture, and biopsy in all HIV patients with DKS, as this will permit the early diagnosis of co-infections and prevent further complications in those who receive chemotherapy.
Assuntos
Infecções Oportunistas Relacionadas com a AIDS/diagnóstico , Medula Óssea/microbiologia , Infecções por HIV/diagnóstico , Histoplasma/crescimento & desenvolvimento , Histoplasmose/diagnóstico , Sarcoma de Kaposi/diagnóstico , Infecções Oportunistas Relacionadas com a AIDS/microbiologia , Infecções Oportunistas Relacionadas com a AIDS/patologia , Infecções Oportunistas Relacionadas com a AIDS/virologia , Adulto , Fosfatase Alcalina/metabolismo , Biomarcadores/metabolismo , Biópsia , Hemocultura , Medula Óssea/metabolismo , Medula Óssea/cirurgia , Medula Óssea/virologia , Proteína C-Reativa/metabolismo , HIV/crescimento & desenvolvimento , HIV/patogenicidade , Infecções por HIV/microbiologia , Infecções por HIV/patologia , Infecções por HIV/virologia , Histoplasma/isolamento & purificação , Histoplasma/patogenicidade , Histoplasmose/microbiologia , Histoplasmose/patologia , Histoplasmose/virologia , Humanos , Masculino , Pessoa de Meia-Idade , Sarcoma de Kaposi/microbiologia , Sarcoma de Kaposi/patologia , Sarcoma de Kaposi/virologiaRESUMO
BACKGROUND: Fluoroquinolones are a popular alternative to trimethoprim-sulfamethoxazole for Stenotrophomonas maltophilia infections. OBJECTIVES: To compare the effects of fluoroquinolones and trimethoprim-sulfamethoxazole on mortality of S. maltophilia infections. DATA SOURCES: PubMed and EMBASE. STUDY ELIGIBILITY CRITERIA: Clinical studies reporting mortality outcomes of S. maltophilia infections. PARTICIPANTS: Patients with clinical infections caused by S. maltophilia. INTERVENTIONS: Fluoroquinolone monotherapy in comparison with trimethoprim-sulfamethoxazole monotherapy. METHODS: Systematic review with meta-analysis technique. RESULTS: Seven retrospective cohort and seven case-control studies were included. Three cohort studies were designed to compare the two drugs, whereas others had other purposes. A total of 663 patients were identified, 332 of which were treated with trimethoprim-sulfamethoxazole (50.1%) and 331 with fluoroquinolones (49.9%). Three cohort studies were designed to compare the effect of the two drugs, whereas the others had other purposes. Levofloxacin was most frequently used among fluoroquinolones (187/331, 56.5%), followed by ciprofloxacin (114/331, 34.4%). The overall mortality rate was 29.6%. Using pooled ORs for the mortality of each study, fluoroquinolone treatment (OR 0.62, 95% CI 0.39-0.99) was associated with survival benefit over trimethoprim-sulfamethoxazole treatment, with low heterogeneity (I2 = 18%). Specific fluoroquinolones such as ciprofloxacin (OR 0.44, 95% CI 0.17-1.12) and levofloxacin (OR 0.78, 95% CI 0.48-1.26) did not show a significant difference in comparison with trimethoprim-sulfamethoxazole. In the sub-group analyses of adult and bacteraemic patients, significant differences in mortality were not observed between fluoroquinolones and trimethoprim-sulfamethoxazole. CONCLUSIONS: Based on a meta-analysis of non-randomized studies, fluoroquinolones demonstrated comparable effects on mortality of S. maltophilia infection to trimethoprim-sulfamethoxazole, supporting the use of fluoroquinolones in clinical S. maltophilia infections. Although the pooled analysis of overall studies favoured fluoroquinolones over trimethoprim-sulfamethoxazole, the studies included were observational, and sub-group analyses of certain fluoroquinolone agents did not show statistical differences with trimethoprim-sulfamethoxazole. Randomized clinical studies are needed to address these issues.
Assuntos
Antibacterianos/uso terapêutico , Fluoroquinolonas/uso terapêutico , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/mortalidade , Stenotrophomonas maltophilia/efeitos dos fármacos , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Infecções por Bactérias Gram-Negativas/microbiologia , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Stenotrophomonas maltophilia/isolamento & purificação , Análise de Sobrevida , Resultado do Tratamento , Adulto JovemRESUMO
BACKGROUND: Hematopoietic stem cell transplantation (HSCT) has been used as treatment in different hematologic and solid malignancies. The aim of this study was to describe the frequency of infectious complications, microbiology, and outcome in patients undergoing HSCT in Mexico during the pre-engraftment period and the impact on mortality rates at 12 months. METHODS: We conducted a retrospective study of all hematologic malignancies that received HSCT from January 2009 and December 2014, at an oncology reference center. RESULTS: We included 210 patients: 144 autologous (69%) and 66 allogeneic HSCT (31%). There were 184 infections documented in 109 patients; incidence rate was 47.2 per 1000 neutropenia/days and 22.4 per 1000 hospitalization/days. The main infections reported were pneumonia (n = 40, 19%), bloodstream infections (n = 36, 17.1%), and central line-associated bloodstream infections (n = 28, 13.3%). There were 110 bacteria isolated, 31 were multidrug-resistant (26 were extended-spectrum beta-lactamase; Escherichia coli). There were 25 disseminated or complicated viral infections and 20 invasive fungal diseases. Fourteen patients died in the first 30 days (all related to the infectious process). In multivariate analysis leukemia, more than 2 chemotherapy regimens before transplant and pneumonia were related to 12-month mortality rates. CONCLUSIONS: Even though infectious processes are frequent in patients with HSCT, multidrug-resistant bacteria were not as frequent as supposed; however, when these microorganisms are involved, mortality rate is increased. It is important to be alert that patients with pneumonia have a significantly increased mortality risk in the first year.
Assuntos
Infecções Bacterianas/epidemiologia , Farmacorresistência Bacteriana Múltipla , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Neutropenia/epidemiologia , Complicações Pós-Operatórias/epidemiologia , Adulto , Idoso , Infecções Bacterianas/microbiologia , Feminino , Neoplasias Hematológicas/microbiologia , Neoplasias Hematológicas/terapia , Humanos , Incidência , Masculino , México/epidemiologia , Pessoa de Meia-Idade , Neutropenia/microbiologia , Complicações Pós-Operatórias/microbiologia , Estudos Retrospectivos , Fatores de Risco , Adulto JovemAssuntos
Hiperplasia do Linfonodo Gigante/diagnóstico , Infecções por HIV/complicações , Herpesvirus Humano 8/isolamento & purificação , Linfonodos/patologia , Sarcoma de Kaposi/complicações , Sarcoma de Kaposi/patologia , Adulto , Fármacos Anti-HIV/uso terapêutico , Antineoplásicos/uso terapêutico , Terapia Antirretroviral de Alta Atividade , Biópsia , Hiperplasia do Linfonodo Gigante/complicações , Hiperplasia do Linfonodo Gigante/tratamento farmacológico , Feminino , Humanos , Linfonodos/virologia , Masculino , Estudos Retrospectivos , Sarcoma de Kaposi/virologia , Coloração e RotulagemRESUMO
OBJECTIVE: To describe overall site-specific hospital-acquired infection (HAI) rates and to describe the microbiological and antibiotic resistance profiles of infecting pathogens, together with their impact on multidrug-resistant (MDR) bacteria-associated mortality. METHODS: We conducted a 5-year retrospective descriptive study of HAI in patients in the intensive care unit (ICU) of a cancer center in Mexico from January 2007 to December 2011. The following information was collected: patient characteristics and comorbidities, data related to the neoplasm and its treatment, microbiology, and the resistance pattern of all isolates. RESULTS: During the study period, 1418 patients were admitted to the ICU; 134 of them developed 159 infections, with an incidence of 11.2/100 hospitalized patients and 32.2/per 1000 patient-days. Two hundred sixty-six microorganisms were isolated. The overall prevalence of MDR-HAI was 39.5%. The most frequent organisms were as follows: 54 (20%) Escherichia coli (94.4% of these were extended-spectrum beta-lactamase producers), 32 (12%) Staphylococcus aureus (90.6% of these were methicillin-resistant), 32 (12%) Enterococcus faecium (18.7% of these were vancomycin-resistant), and 20 (6%) Acinetobacter baumannii (all were MDR). Among patients admitted to the ICU, 252 (17.8%) died. Death was related to the HAI in 58 (23%) of these patients (p<0.001) and 51 (88%) had a MDR organism isolated (p=0.05). CONCLUSIONS: The emergence of MDR bacteria poses a difficult task for physicians, who have limited therapeutic options. Critically ill cancer patients admitted to the ICU are at major risk of a bacterial MDR-HAI that will impact adversely on mortality.
Assuntos
Infecção Hospitalar/epidemiologia , Farmacorresistência Bacteriana Múltipla , Unidades de Terapia Intensiva , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Bactérias/isolamento & purificação , Infecção Hospitalar/microbiologia , Infecção Hospitalar/mortalidade , Feminino , Humanos , Masculino , Oncologia , Pessoa de Meia-Idade , Prevalência , Estudos Retrospectivos , Adulto JovemRESUMO
BACKGROUND: Vibrio vulnificus is a marine bacteria associated with the ingestion of raw shellfish or contact with seawater. It can produce wound infection, diarrhea and sepsis. The main risk factor for infection is the presence of chronic liver disease. Prior studies have shown mortality from 40% to 63%. OBJECTIVE: Report of 8 cases of disseminated infection with V. vulnificus causing fulminant sepsis. DESIGN: Series of cases. METHODS: We reviewed the database of the laboratory of clinical microbiology from 1990 to 1999. A computer-based review of the worldwide medical literature was also accomplished. RESULTS: There were 8 cases of V. vulnificus infection. All patients had chronic liver disease, 3 also had diabetes mellitus and 1 received immunosuppressive agents. Five patients were known to have ingested raw shellfish. The mean duration of illness before death was 4 days. All patients presented with sepsis, seven had cutaneous lesions. Five patients received early antimicrobial treatment during the first 24 hours and all of them in the first 48 hours. Regardless of susceptibility to the antimicrobial agents used, the mortality was of 87.5%. Disk-diffusion test showed 100% susceptibility to imipenem, ceftazidime and tetracycline; 83% to cefepime, ticarcillin and cotrimoxazole and 50% to quinolones. CONCLUSION: The V. vulnificus infection appears in patients with chronic liver disease and it is associated with high mortality. This infection has to be suspected in high-risk patients who have eaten raw shellfish and therapy must be initiated as soon as possible.
Assuntos
Sepse/virologia , Vibrioses/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Vibrioses/epidemiologiaRESUMO
Resumen La meningitis bacteriana aguda es una enfermedad infecciosa, considerada una urgencia médica. La mortalidad secundaria alcanza hasta 37% y las secuelas neurológicas se estiman en 52% de los adultos supervivientes. El diagnóstico y tratamiento oportunos tiene una importante repercusión en la evolución de la enfermedad. Comunicamos el caso de un paciente de 33 años de edad, con antecedente de sinusitis crónica, sometido a tratamiento quirúrgico mediante rinoplastia electiva. En el periodo posquirúrgico inició con desorientación, agitación psicomotriz, fiebre, rigidez de la nuca y convulsiones tónico-clónicas generalizadas. Se realizó tomografía de cráneo, que reportó sinusitis etmoidal y esfenoidal. Ingresó a la unidad de cuidados intensivos debido a que requirió apoyo mecánico ventilatorio; recibió tratamiento empírico con esteroides, ceftriaxona y vancomicina. Se le realizó punción lumbar y el análisis del líquido cefalorraquídeo fue sugerente de infección piógena. El cultivo desarrolló Streptococcus pneumoniae sensible a penicilina, por lo que se ajustó el tratamiento antimicrobiano con penicilina G sódica cristalina. El paciente egresó 15 días después, sin secuelas neurológicas. En pacientes con factores de riesgo y un cuadro clínico sugerente de meningitis bacteriana debe iniciarse el tratamiento antibótico lo antes posible, con la finalidad de disminuir la mortalidad y las complicaciones asociadas.
Abstract Acute bacterial meningitis is considered a medical emergency. Mortality is up to 37% and the neurological sequels are estimated at 52% in the survivors. The timely management and diagnosis have a significant impact on the evolution of the disease. This paper reports the case of a 33-year-old male with a history of chronic sinusitis, he was summited to an elective rhinoplasty, and 24 hours after the surgery the patient began with disorientation, psychomotor agitation, fever, neck stiffness and generalized tonic-clonic seizures. Cranial CT showed ethmoidal and sphenoidal sinusitis. Lumbar puncture was done and the cerebrospinal fluid (CFS) analysis was suggestive of pyogenic infection. Patient was admitted to the intensive care unit (ICU) with mechanical ventilation. Empirical treatment with steroids, ceftriaxone and vancomycin was started. The cerebrospinal fluid culture revealed Streptococcus pneumoniae penicillin susceptible. Antimicrobial treatment was adjusted to penicillin G, and after 15 days patient was sent to home without any neurological damage. In patients with risk factors and a clinical picture suggestive of bacterial meningitis treatment should be started as soon as possible, with the aim of reducing the mortality and the associated complications.
RESUMO
Echinococcosis is a parasitic disease that involves dogs as definitive host and sheep as intermediate host. Humans become infected incidentally through fecal-oral contact, particularly in the course of playful and close contact with an infected dog. Mexico is considered a region that is virtually free of cystic echinoccocosis. This manuscript describes two cases that were referred to a tertiary-care oncology hospital with a diagnosis of cancer. In one case, the presumptive diagnosis was liver cancer because abdominal ultrasonography revealed a low-density mass in the right hepatic lobe. Drainage was performed and cytologic examination of the fluid showed multiple Echinococcus cyst as well as prostoscolex. The case was resolved with percutaneous drainage and administration of albendazole for two months. In the second case, the patient was referred with a diagnosis of disseminated cervical cancer. A cyst was identified in the upper right lung lobe; a diagnostic puncture was performed showing an Echinococcus cyst. This resolved solely with two months of albendazole administration.
La equinococosis, conocida también como hidatidosis, es una enfermedad parasitaria que comprende a los perros como hospedador definitivo y a las ovejas como huésped intermedio. Los seres humanos se infectan casualmente por contacto feco-oral, particularmente al jugar y estar en estrecho contacto con un perro infectado. México es considerado una región que está prácticamente libre de equinococosis quística. Este trabajo describe dos casos que fueron referidos con un diagnóstico de cáncer a un hospital oncológico de atención terciaria. En un caso, el diagnóstico presuntivo fue cáncer del hígado, porque la ultrasonografía abdominal reveló una masa de baja densidad en el lóbulo hepático derecho. Se hizo un drenaje y el examen citológico del fluido mostró quistes múltiples de equinococos así como la presencia de protoescólex. El caso se resolvió con drenaje percutáneo y administración de albendazol durante dos meses. En el segundo caso, la paciente fue remitida con un diagnóstico de cáncer cervical diseminado. Se identificó un quiste en el lóbulo superior de pulmón derecho. La punción diagnóstica realizada reveló un quiste equinocócico, que se resolvió simplemente con dos meses de administración de albendazol.